Free/Total PSA (F/T ratio) kinetics in patients with clinically localized prostate cancer undergoing radical prostatectomy

被引:13
|
作者
Gregorakis, AK
Malovrouvas, D
Stefanakis, S
Petraki, K
Scorilas, A [1 ]
机构
[1] Univ Athens, Fac Biol, Dept Biochem & Mol Biol, Athens 15701, Greece
[2] Univ Athens, Attikon Gen Hosp, Dept Urol, Athens, Greece
[3] Evangelismos Gen Hosp, Dept Urol, Athens, Greece
[4] Evangelismos Gen Hosp, Dept Pathol, Athens, Greece
关键词
tumor biomarkers; kallikreins; prostate; prostate cancer; PSA; free PSA; prostate specific antigen; serine proteases;
D O I
10.1016/j.cccn.2005.03.027
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: In this paper we study the Free/Total PSA kinetics in patients with clinically localized prostate cancer undergoing radical prostatectomy. Methods: Serum PSA, Free PSA and Free/Total Ratio were determined preoperatively, at the time of prostate removal (0 time) and then at 3, 6, 12, 24, 48, 72 and 168 h, from 9 patients with clinically localized prostate cancer who underwent radical retropubic prostatectomy. The elimination rates and half-lives of Total, Free PSA and F/T Ratio were studied applying one and two compartment models for pharmacokinetic analysis. Results: Surgical manipulations of the prostate caused a mean 2.16-fold increase. of PSA, 12-fold increase of free PSA and 4.2-fold increase of F/T PSA ratio. Removal of the prostate caused a rapid biphasic, biexponential elimination of Free PSA with a mean half-life of 0.8 h for the alpha (a) phase and 32.6 h for the beta (b) phase. PSA was eliminated following a rapid exponential (a) phase with a half-life of 1.15 h and a non-exponential (b) phase with a half-life of 71.96 h. Free/Total PSA followed a biphasic kinetic, with an initial exponential elimination phase and a mean half-life of 2.6 h and a second non-exponential increase phase with a doubling time of 130.8 h. Free/Total PSA reached its nadir very soon, at the first postoperative 24 h. Conclusions: Free/Total PSA kinetic after radical prostatectomy reflects the differences of Free and Total PSA elimination kinetics. Free/Total Ratio follows a biphasic kinetic, with an initial rapid exponential elimination phase, which is affected mainly by the rapid exponential (a) phase of Free PSA elimination and a second slow increase, which is affected mainly by the terminal non-exponential (b) phase of PSA elimination. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:196 / 201
页数:6
相关论文
共 50 条
  • [31] The impact of statins use in clinically localized prostate cancer treated with radical prostatectomy
    Rijo Mora, Enrique
    Lorente Garin, Jose A.
    Bielsa Gali, Oscar
    Frances Comalat, Albert
    Fumado Ciutat, Lluis
    Arango Toro, Octavio
    ACTAS UROLOGICAS ESPANOLAS, 2009, 33 (04): : 351 - 355
  • [32] Hazard rates for progression after radical prostatectomy for clinically localized prostate cancer
    Dillioglugil, O
    Leibman, BD
    Kattan, MW
    SealeHawkins, C
    Wheeler, TM
    Scardino, PT
    UROLOGY, 1997, 50 (01) : 93 - 99
  • [33] Management of clinically localized prostate cancer by radical prostatectomy followed by watchful waiting
    Kirby, R
    NATURE CLINICAL PRACTICE UROLOGY, 2005, 2 (06): : 298 - 303
  • [34] Cancer to total prostate volume ratio influences patholgical parameters and biochemical recurrence in localized prostate cancer treated by radical prostatectomy
    Sim, Hong Gee
    Telesca, Donatello
    Culp, Stephen H.
    Lange, Paul H.
    Ellis, William J.
    True, Lawrence D.
    Lin, Daniel W.
    JOURNAL OF UROLOGY, 2007, 177 (04): : 340 - 340
  • [35] Partin tables do not adequately predict the risk of lymph node involvement in patients undergoing radical prostatectomy for clinically localized prostate cancer
    Heidenreich, A
    Ohlmann, CH
    Schuhmacher, M
    Engelmann, UH
    Studer, UE
    JOURNAL OF UROLOGY, 2006, 175 (04): : 213 - 213
  • [36] The percentage of free prostate-specific antigen does not predict extracapsular disease in patients with clinically localized prostate cancer before radical prostatectomy
    Melchior, SW
    Noteboom, J
    Gillitzer, R
    Lange, PH
    Blumenstein, BA
    Vessella, RL
    BJU INTERNATIONAL, 2001, 88 (03) : 221 - 225
  • [37] P53 nuclear protein expression is an independent prognostic marker in clinically localized prostate cancer patients undergoing radical prostatectomy
    Bauer, JJ
    Sesterhenn, IA
    Mostofi, KF
    McLeod, DG
    Srivastava, S
    Moul, JW
    CLINICAL CANCER RESEARCH, 1995, 1 (11) : 1295 - 1300
  • [38] SERUM TESTOSTERONE CAN AFFECT PREOPERATIVE URINARY CONTINENCE AND ERECTILE FUNCTION IN PATIENTS UNDERGOING RADICAL PROSTATECTOMY FOR CLINICALLY LOCALIZED PROSTATE CANCER
    Gacci, Mauro
    Corona, Giovanni
    Tosi, Nicola
    Masieri, Lorenzo
    Lanciotti, Michele
    Giancane, Saverio
    Raugei, Andrea
    Vittori, Gianni
    Apolone, Giovanni
    Morelli, Annamaria
    Filippi, Sandra
    Fibbi, Benedetta
    Vignozzi, Linda
    Vannelli, Gabriella
    Lapini, Alberto
    Semi, Sergio
    Maggi, Mario
    Carini, Marco
    ANTICANCER RESEARCH, 2010, 30 (04) : 1394 - 1395
  • [39] THE INFLUENCE OF INCREASED BMI AS RISK FACTOR OF LOCALIZED PROSTATE CANCER IN PATIENTS UNDERGOING RADICAL PROSTATECTOMY
    Gbenou, Maximilien Goris
    Peltier, Alexandre
    Lopez, Jean-Gabriel
    Van, Roland
    JOURNAL OF UROLOGY, 2012, 187 (04): : E538 - E538
  • [40] Prevention Technique of Postoperative Inguinal Hernia in Patients Undergoing Radical Prostatectomy for Localized Prostate Cancer
    Hori S.
    Oyama N.
    Miyake M.
    Toyoshima Y.
    Takada S.
    Fujimoto K.
    Ono T.
    Momose H.
    Indian Journal of Surgical Oncology, 2017, 8 (1) : 9 - 13